Pedro Lylyk
Research Subjects
Pedro Lylyk has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Ivan Lylyk
Department of Neuroradiology, Clínica La Sagrada Familia, Buenos Aires, Argentina
4 shared publications - Carlos Bleise
Department of Interventional Neuroradiology, Instituto Clinico ENERI, Buenos Aires, Argentina
3 shared publications - Esteban Scrivano
Division of Neurosurgery, ENERI Medical Institute, Equipo de Neurocirugia Endovascular y Radiologia Intervencionista, Buenos Aires, Argentina (P.L., I.L., C.B., E.S., P.N.L.).
3 shared publications C. Toranzo
General Manager ENERI (Equipo de Neurocirugía Endovascular y Radiología Intervencionista) and Clínica La Sagrada Familia, Buenos Aires, Argentina
2 shared publications- Diana Paredes-Ruiz
Medtronic Senior Health Policy Specialist - Health Economics & Reimbursement, Santiago, RM, Chile
2 shared publications - Eleonora Aiello
Independent Consultant, Buenos Aires, Argentina
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (3)
First-in-Human Treatment of Medically Refractory Idiopathic Intracranial Hypertension With the eShunt System: Case Report
- 1 May 2026
- Published by Wolters Kluwer Health in Stroke: Vascular and Interventional Neurology
- Vol. 6 (3)
Open AccessFirst-in-Human Treatment of Medically Refractory Idiopathic Intracranial Hypertension With the eShunt System: Case Report
- 15 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (747) , eadl4497
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe
Endovascular interventions are increasingly becoming the preferred approach for treating strokes and cerebral artery diseases. These procedures rely on sophisticated angiographical imaging guidance, which encounters challenges because of limited contrast and spatial resolution. Achieving a more precise visualization of the underlying arterial pathology and neurovascular implants is crucial for accurate procedural decision-making. In a human study involving 32 patients, we introduced the clinical application of a miniaturized endovascular neuro optical coherence tomography ( n OCT) imaging probe. This technology was designed to navigate the tortuous paths of the cerebrovascular circulation and to offer high-resolution imaging in situ. The n OCT probe is compatible with standard neurovascular microcatheters, integrating with the procedural workflow used in clinical routine. Equipped with a miniaturized optical fiber and a distal lens, the probe illuminates the tissue and collects the backscattered, near-infrared light. While rotating the fiber and the lens at high speed, the probe is rapidly retracted, creating a spiral-shaped light pattern to comprehensively capture the arterial wall and implanted devices. Using n OCT, we demonstrated volumetric microscopy of cerebral arteries in patients undergoing endovascular procedures. We imaged the anterior and posterior circulation of the brain, including distal segments of the internal carotid and middle-cerebral arteries, as well as the vertebral, basilar, and posterior cerebral arteries. We captured a broad spectrum of neurovascular pathologies, such as brain aneurysms, ischemic stroke, arterial stenoses, dissections, and intracranial atherosclerotic disease. n OCT offered artifact-free, high-resolution visualizations of intracranial artery pathology and neurovascular devices.
- 15 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 16 (747) , eadl4497
Volumetric microscopy of cerebral arteries with a miniaturized optical coherence tomography imaging probe
Endovascular interventions are increasingly becoming the preferred approach for treating strokes and cerebral artery diseases. These procedures rely on sophisticated angiographical imaging guidance, which encounters challenges because of limited contrast and spatial resolution. Achieving a more precise visualization of the underlying arterial pathology and neurovascular implants is crucial for accurate procedural decision-making. In a human study involving 32 patients, we introduced the clinical application of a miniaturized endovascular neuro optical coherence tomography ( n OCT) imaging probe. This technology was designed to navigate the tortuous paths of the cerebrovascular circulation and to offer high-resolution imaging in situ. The n OCT probe is compatible with standard neurovascular microcatheters, integrating with the procedural workflow used in clinical routine. Equipped with a miniaturized optical fiber and a distal lens, the probe illuminates the tissue and collects the backscattered, near-infrared light. While rotating the fiber and the lens at high speed, the probe is rapidly retracted, creating a spiral-shaped light pattern to comprehensively capture the arterial wall and implanted devices. Using n OCT, we demonstrated volumetric microscopy of cerebral arteries in patients undergoing endovascular procedures. We imaged the anterior and posterior circulation of the brain, including distal segments of the internal carotid and middle-cerebral arteries, as well as the vertebral, basilar, and posterior cerebral arteries. We captured a broad spectrum of neurovascular pathologies, such as brain aneurysms, ischemic stroke, arterial stenoses, dissections, and intracranial atherosclerotic disease. n OCT offered artifact-free, high-resolution visualizations of intracranial artery pathology and neurovascular devices.
- Open Access
- 22 December 2023
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 72 (2)
THE INFLUENCE OF VESSEL CURVATURE AND THROMBUS COMPOSITION ON THE EFFECTIVENESS AND OUTCOMES OF THROMBECTOMY IN THE CASE OF ACUTE ISCHEMIC STROKE
Introduction. It is believed that vascular anatomy has a direct influence on the complexity and course of mechanical thrombectomy, and its outcome determines the degree of reperfusion and clinical effect. Aim. To analyze the influence of the curvature of the intracranial arteries and the composition of the thrombus on the results of thrombectomy. Materials and methods. 64 patients who underwent mechanical thrombectomy for acute proximal occlusion of the ICA or MCA were prospectively examined. (44man/20women among them, the age of the patients ranged from 47-89years (67.2±1.2). The study was performed by measuring the ICA-M1 angle on angiograms in direct projection. Angles were compared between patients with successful (mTICI group 2b/3) and unsuccessful (mTICI group 0-2a) reperfusion. The functional result was evaluated according to the mRS scale as positive (0-3) and negative (4-5). Removed thrombi were examined by light microscopy with hematoxylin-eosin and orange-red-blue staining. Results. Among patients of the mTICI 2b/3 group, a larger angle of the ICA-M1 was measured (126.4±2.8°) compared to patients in the mTICI 0-2a group - 107.1±4.9° (p=0.05). Among patients with 1-2 passages, statistically significantly larger ICA-M1 angles were recorded (129.8±3.3°) than among patients with a number of passages >2 (109.2±5,7°, p<0.02). The duration of mechanical thrombectomy was 60 min) (p<0.05). Successful reperfusion (group mTICI 2b/3) was achieved in 47 (73.4%) patients. A clinically positive result(mRS 0-3) was observed among 37(57.8%) patients. During microscopic examination of thrombi among patient groups mTICI 0/2a, fibrin threads with signs of aging with purple and blue color were present on the periphery (24-48hours). With a favorable outcome of the operation, the coagulated fibrin fibers were stained red (<16hours). Conclusions. With a smaller curvature of the ICA and its branches, and in the presence of "fresh" thrombi, the efficiency of operations increases, and the number of passages and the duration of mechanical thrombectomy decrease. The neurological status of patients at admission correlates with the functional outcome at the time of discharge.
- 22 December 2023
- Published by Danylo Halytskyi Lviv National Medical University in Proceeding of the Shevchenko Scientific Society. Medical Sciences
- Vol. 72 (2)
Open AccessTHE INFLUENCE OF VESSEL CURVATURE AND THROMBUS COMPOSITION ON THE EFFECTIVENESS AND OUTCOMES OF THROMBECTOMY IN THE CASE OF ACUTE ISCHEMIC STROKE
Introduction. It is believed that vascular anatomy has a direct influence on the complexity and course of mechanical thrombectomy, and its outcome determines the degree of reperfusion and clinical effect. Aim. To analyze the influence of the curvature of the intracranial arteries and the composition of the thrombus on the results of thrombectomy. Materials and methods. 64 patients who underwent mechanical thrombectomy for acute proximal occlusion of the ICA or MCA were prospectively examined. (44man/20women among them, the age of the patients ranged from 47-89years (67.2±1.2). The study was performed by measuring the ICA-M1 angle on angiograms in direct projection. Angles were compared between patients with successful (mTICI group 2b/3) and unsuccessful (mTICI group 0-2a) reperfusion. The functional result was evaluated according to the mRS scale as positive (0-3) and negative (4-5). Removed thrombi were examined by light microscopy with hematoxylin-eosin and orange-red-blue staining. Results. Among patients of the mTICI 2b/3 group, a larger angle of the ICA-M1 was measured (126.4±2.8°) compared to patients in the mTICI 0-2a group - 107.1±4.9° (p=0.05). Among patients with 1-2 passages, statistically significantly larger ICA-M1 angles were recorded (129.8±3.3°) than among patients with a number of passages >2 (109.2±5,7°, p<0.02). The duration of mechanical thrombectomy was 60 min) (p<0.05). Successful reperfusion (group mTICI 2b/3) was achieved in 47 (73.4%) patients. A clinically positive result(mRS 0-3) was observed among 37(57.8%) patients. During microscopic examination of thrombi among patient groups mTICI 0/2a, fibrin threads with signs of aging with purple and blue color were present on the periphery (24-48hours). With a favorable outcome of the operation, the coagulated fibrin fibers were stained red (<16hours). Conclusions. With a smaller curvature of the ICA and its branches, and in the presence of "fresh" thrombi, the efficiency of operations increases, and the number of passages and the duration of mechanical thrombectomy decrease. The neurological status of patients at admission correlates with the functional outcome at the time of discharge.
- Open Access
- 5 January 2022
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 14 (10) , 968-972
Ophthalmic artery angioplasty for age-related macular degeneration
Background There is considerable overlap of contributors to cardiovascular disease and the development of age-related macular degeneration (AMD). Compromised ocular microcirculation due to aging and vascular disease contribute to retinal dysfunction and vision loss. Decreased choroidal perfusion is evident in eyes with dry AMD and is thought to play a role in retinal pigment epithelial dysfunction, the rate of development of geographic atrophy, and the development of neovascularization. The aim of the study was to demonstrate that AMD is correlated with a compromised blood flow in the ocular pathway and show OA angioplasty as a potential treatment of late-stage AMD. Methods Based on the potential for the ophthalmic artery (OA) to be an anatomical target for the treatment of AMD as outlined above, five patients were found to be eligible for compassionate use treatment, presenting clinically significant late-stage AMD with profound vision loss in one or both eyes, and are included in this retrospective study. Results OA narrowing, or significant calcium burden at the ophthalmic segment of the internal carotid artery compromising the origin of the OA was confirmed in all cases. Subsequent OA cannulation was achieved in all patients with some difficulty. Subjective patient reports indicated that all patients perceived a benefit following the procedure; however, improved postoperative visual acuity did not confirm that perceived benefit for one of the patients. Conclusions Feasibility and safety of the OA angioplasty were demonstrated, and a benefit perceived in five patients with profound vision loss and a desire to achieve improved quality of life. A clinical trial with controlled schedule, imaging, and methodologies is needed to confirm these results.
- 5 January 2022
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 14 (10) , 968-972
Open AccessOphthalmic artery angioplasty for age-related macular degeneration
Background There is considerable overlap of contributors to cardiovascular disease and the development of age-related macular degeneration (AMD). Compromised ocular microcirculation due to aging and vascular disease contribute to retinal dysfunction and vision loss. Decreased choroidal perfusion is evident in eyes with dry AMD and is thought to play a role in retinal pigment epithelial dysfunction, the rate of development of geographic atrophy, and the development of neovascularization. The aim of the study was to demonstrate that AMD is correlated with a compromised blood flow in the ocular pathway and show OA angioplasty as a potential treatment of late-stage AMD. Methods Based on the potential for the ophthalmic artery (OA) to be an anatomical target for the treatment of AMD as outlined above, five patients were found to be eligible for compassionate use treatment, presenting clinically significant late-stage AMD with profound vision loss in one or both eyes, and are included in this retrospective study. Results OA narrowing, or significant calcium burden at the ophthalmic segment of the internal carotid artery compromising the origin of the OA was confirmed in all cases. Subsequent OA cannulation was achieved in all patients with some difficulty. Subjective patient reports indicated that all patients perceived a benefit following the procedure; however, improved postoperative visual acuity did not confirm that perceived benefit for one of the patients. Conclusions Feasibility and safety of the OA angioplasty were demonstrated, and a benefit perceived in five patients with profound vision loss and a desire to achieve improved quality of life. A clinical trial with controlled schedule, imaging, and methodologies is needed to confirm these results.
- Open Access
- 7 June 2021
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 89 (3) , 443-449
Pipeline Embolization Devices for the Treatment of Intracranial Aneurysms, Single-Center Registry: Long-Term Angiographic and Clinical Outcomes from 1000 Aneurysms
BACKGROUND: Prospective studies have established the safety and efficacy of the PipelineTM Embolization Device (PED; Medtronic) for treatment of intracranial aneurysms (IA). OBJECTIVE: To investigate long-term outcomes from the Pipeline Embolization Devices for the Treatment of Intracranial Aneurysms (PEDESTRIAN) Registry. METHODS: The PEDESTRIAN Registry data were retrospectively reviewed, which included patients (March 2006 to July 2019) with complex IAs treated with PED. Patients with unfavorable anatomy and/or recurrence following previous treatment were included and excluded those with acute subarachnoid hemorrhage. The primary angiographic endpoint was complete occlusion and long-term stability. Clinical and radiological follow-up was performed at 3 to 6 mo, 12 mo, and yearly thereafter. RESULTS: A total of 835 patients (mean age 55.9 ± 14.7 yr; 80.0% female) with 1000 aneurysms were included. Aneurysms varied in size: 64.6% were small (≤10 mm), 25.6% were large (11-24 mm), and 9.8% were giant (≥25 mm). A total of 1214 PEDs were deployed. Follow-up angiography was available for 85.1% of patients with 776 aneurysms at 24.6 ± 25.0 mo (mean). Complete occlusion was demonstrated in 75.8% of aneurysms at 12 mo, 92.9% at 2 to 4 yr, and 96.4% at >5 yr. During the postprocedural period, modified Rankin Scale scores remained stable or improved in 96.2% of patients, with stability or improvement in 99.1% of patients >5 yr. The overall major morbidity and neurological mortality rate was 5.8%. CONCLUSION: This study demonstrated high rates of long-term complete aneurysm occlusion, stable or improved functional outcomes, and low rates of complications and mortality. Clinical and angiographic outcomes improved over long-term follow-up, demonstrating that endovascular treatment of IA with PED is safe and effective.
- 7 June 2021
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 89 (3) , 443-449
Open AccessPipeline Embolization Devices for the Treatment of Intracranial Aneurysms, Single-Center Registry: Long-Term Angiographic and Clinical Outcomes from 1000 Aneurysms
BACKGROUND: Prospective studies have established the safety and efficacy of the PipelineTM Embolization Device (PED; Medtronic) for treatment of intracranial aneurysms (IA). OBJECTIVE: To investigate long-term outcomes from the Pipeline Embolization Devices for the Treatment of Intracranial Aneurysms (PEDESTRIAN) Registry. METHODS: The PEDESTRIAN Registry data were retrospectively reviewed, which included patients (March 2006 to July 2019) with complex IAs treated with PED. Patients with unfavorable anatomy and/or recurrence following previous treatment were included and excluded those with acute subarachnoid hemorrhage. The primary angiographic endpoint was complete occlusion and long-term stability. Clinical and radiological follow-up was performed at 3 to 6 mo, 12 mo, and yearly thereafter. RESULTS: A total of 835 patients (mean age 55.9 ± 14.7 yr; 80.0% female) with 1000 aneurysms were included. Aneurysms varied in size: 64.6% were small (≤10 mm), 25.6% were large (11-24 mm), and 9.8% were giant (≥25 mm). A total of 1214 PEDs were deployed. Follow-up angiography was available for 85.1% of patients with 776 aneurysms at 24.6 ± 25.0 mo (mean). Complete occlusion was demonstrated in 75.8% of aneurysms at 12 mo, 92.9% at 2 to 4 yr, and 96.4% at >5 yr. During the postprocedural period, modified Rankin Scale scores remained stable or improved in 96.2% of patients, with stability or improvement in 99.1% of patients >5 yr. The overall major morbidity and neurological mortality rate was 5.8%. CONCLUSION: This study demonstrated high rates of long-term complete aneurysm occlusion, stable or improved functional outcomes, and low rates of complications and mortality. Clinical and angiographic outcomes improved over long-term follow-up, demonstrating that endovascular treatment of IA with PED is safe and effective.